Effects of an Extensively Hydrolyzed Formula Supplemented with Two Human Milk Oligosaccharides on Growth, Tolerability, Safety and Infection Risk in Infants with Cow’s Milk Protein Allergy: A Randomized, Multi-Center Trial

Effects of an Extensively Hydrolyzed Formula Supplemented with Two Human Milk Oligosaccharides on Growth, Tolerability, Safety and Infection Risk in Infants with Cow’s Milk Protein Allergy: A Randomized, Multi-Center Trial

This randomized clinical trial (Registration: NCT03085134) assessed if an extensively hydrolyzed formula (EHF) supplemented with two human milk oligosaccharides (HMO) and reduced protein content (2.20 g/100 kcal) supports normal growth in infants with cow’s milk protein allergy (CMPA). Secondary out...

Full description

Bibliographic Details
Main Authors: Yvan Vandenplas, Marta Żołnowska, Roberto Berni Canani, Siân Ludman, Zsuzsanna Tengelyi, Ana Moreno-Álvarez, Anne E. N. Goh, Maria Laura Gosoniu, Bridget-Anne Kirwan, Monika Tadi, Ralf G. Heine, CINNAMON Study Investigator Group
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Nutrients
Subjects:
2′-fucosyllactose
lacto-N-neotetraose
food allergy
whey hydrolysate
respiratory infection
otitis media
Online Access:https://www.mdpi.com/2072-6643/14/3/530

Internet

https://www.mdpi.com/2072-6643/14/3/530

Similar Items